These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 8521129)
1. Preoperative estimate of extent of disease in T1c: how well can we predict? Austenfeld MS Semin Urol Oncol; 1995 Aug; 13(3):176-80. PubMed ID: 8521129 [TBL] [Abstract][Full Text] [Related]
2. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. Presti JC; Hovey R; Carroll PR; Shinohara K J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571 [TBL] [Abstract][Full Text] [Related]
4. Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer. Bianco FJ; Mallah KN; Korets R; Hricak H; Scardino PT; Kattan MW Urology; 2007 Feb; 69(2):343-6. PubMed ID: 17320675 [TBL] [Abstract][Full Text] [Related]
5. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695 [TBL] [Abstract][Full Text] [Related]
6. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [TBL] [Abstract][Full Text] [Related]
7. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Anast JW; Andriole GL; Bismar TA; Yan Y; Humphrey PA Urology; 2004 Sep; 64(3):544-50. PubMed ID: 15351590 [TBL] [Abstract][Full Text] [Related]
8. Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer. Loeb S; Roehl KA; Thaxton CS; Catalona WJ Urology; 2008 Jul; 72(1):143-7. PubMed ID: 18436287 [TBL] [Abstract][Full Text] [Related]
9. Stage T1c prostate cancer: perspectives on clinical management. Smith JA Semin Urol Oncol; 1995 Aug; 13(3):238-44. PubMed ID: 8521137 [TBL] [Abstract][Full Text] [Related]
10. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade. Haese A; Vaisanen V; Lilja H; Kattan MW; Rittenhouse HG; Pettersson K; Chan DW; Huland H; Sokoll LJ; Partin AW J Urol; 2005 Mar; 173(3):752-6. PubMed ID: 15711262 [TBL] [Abstract][Full Text] [Related]
11. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml. Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888 [TBL] [Abstract][Full Text] [Related]
12. Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3). Aus G; Becker C; Lilja H; Khatami A; Pihl CG; Hugosson J Scand J Urol Nephrol; 2003; 37(6):466-70. PubMed ID: 14675918 [TBL] [Abstract][Full Text] [Related]
13. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL; J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734 [TBL] [Abstract][Full Text] [Related]
14. A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes? Thong AE; Shikanov S; Katz MH; Gofrit ON; Eggener S; Zagaja GP; Shalhav AL; Zorn KC J Urol; 2008 Dec; 180(6):2436-40. PubMed ID: 18930486 [TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of final pathological features is not improved by the free-to-total prostate-specific antigen ratio in Japanese men with clinically localized prostate cancer. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2005 Feb; 12(2):182-6. PubMed ID: 15733113 [TBL] [Abstract][Full Text] [Related]
16. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate-specific antigen levels < or = 10 ng/ml. Stephan C; Jung K; Cammann H Cancer; 2004 May; 100(9):1989-90; author reply 1989-90. PubMed ID: 15112283 [No Abstract] [Full Text] [Related]
17. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484 [TBL] [Abstract][Full Text] [Related]
18. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL. Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828 [TBL] [Abstract][Full Text] [Related]
19. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge. Veltri RW; Miller MC; Mangold LA; O'Dowd GJ; Epstein JI; Partin AW J Urol; 2002 Jul; 168(1):100-4. PubMed ID: 12050500 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]